Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doripenem versus cefepime in hospitalized children with complicated urinary tract infection
2009-015953-18Phase 3Terminated
- Sponsor
- Janssen Pharmaceutical
- Start
- Mar 2010
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in complicated urinary tract infection (cUTI) and urinary tract infection (UTI) comparing Doripenem with Cefepime (2 arms). Primary endpoints: Adverse events, Clinical laboratory tests and 1 more. Started Mar 2010; status: terminated.
02
Drugs
doripenemcefepime
03
Conditions
complicated urinary tract infection (cUTI)urinary tract infection (UTI)
Beyond the preview
Go deeper on 2009-015953-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-015953-18.